CAMBRIDGE, Mass., July 6, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the JMP Securities Healthcare Conference in New York City. Mark Fitzpatrick, CFO of Aegerion, is scheduled to present on Friday, July 13, 2012 at 11:30 a.m. ET.
